Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
GlaxoSmithKline ( (GB:GSK) ) has shared an announcement.
GSK plc has continued its share buyback programme, repurchasing 330,000 ordinary shares on 17 April 2026 through BNP Paribas at a volume-weighted average price of 2,126.15p per share. The shares will be held in treasury, taking treasury holdings to 259,747,615 shares and leaving 4,056,451,419 shares in issue, with treasury shares representing 6.40% of voting rights.
The latest transaction brings total repurchases since 17 February 2026 to 19,856,521 shares, underscoring GSK’s ongoing capital-return strategy and active management of its share capital structure. The updated voting rights figure provides a new reference point for investors monitoring disclosure thresholds under U.K. transparency rules, with implications for regulatory reporting by significant shareholders.
The most recent analyst rating on (GB:GSK) stock is a Hold with a £22.50 price target. To see the full list of analyst forecasts on GlaxoSmithKline stock, see the GB:GSK Stock Forecast page.
Spark’s Take on GSK Stock
According to Spark, TipRanks’ AI Analyst, GSK is a Neutral.
The score is driven primarily by strong profitability and improving recent fundamentals, supported by constructive 2026 guidance and pipeline momentum. Valuation is reasonable with a modest yield, while the main constraint is technical overbought risk and ongoing balance-sheet/earnings-consistency considerations.
To see Spark’s full report on GSK stock, click here.
More about GlaxoSmithKline
GSK plc is a global biopharmaceutical company focused on developing, manufacturing and commercializing vaccines and specialty medicines. The group targets infectious diseases, HIV, respiratory and immunology, and oncology, leveraging its research and development capabilities to grow in key prescription and vaccine markets worldwide.
Average Trading Volume: 9,512,590
Technical Sentiment Signal: Buy
Current Market Cap: £85.13B
For an in-depth examination of GSK stock, go to TipRanks’ Overview page.